Assertio (ASRT) Competitors $0.94 -0.02 (-1.98%) As of 12:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ASRT vs. OCGN, AMRN, MNPR, SCPH, GLUE, MREO, FHTX, ENGN, CAPR, and KRROShould you be buying Assertio stock or one of its competitors? The main competitors of Assertio include Ocugen (OCGN), Amarin (AMRN), Monopar Therapeutics (MNPR), scPharmaceuticals (SCPH), Monte Rosa Therapeutics (GLUE), Mereo BioPharma Group (MREO), Foghorn Therapeutics (FHTX), enGene (ENGN), Capricor Therapeutics (CAPR), and Korro Bio (KRRO). These companies are all part of the "pharmaceutical products" industry. Assertio vs. Its Competitors Ocugen Amarin Monopar Therapeutics scPharmaceuticals Monte Rosa Therapeutics Mereo BioPharma Group Foghorn Therapeutics enGene Capricor Therapeutics Korro Bio Assertio (NASDAQ:ASRT) and Ocugen (NASDAQ:OCGN) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings. Is ASRT or OCGN more profitable? Assertio has a net margin of -36.97% compared to Ocugen's net margin of -1,197.71%. Assertio's return on equity of -38.19% beat Ocugen's return on equity.Company Net Margins Return on Equity Return on Assets Assertio-36.97% -38.19% -15.45% Ocugen -1,197.71%-255.25%-86.79% Do analysts prefer ASRT or OCGN? Assertio presently has a consensus target price of $2.38, suggesting a potential upside of 155.38%. Ocugen has a consensus target price of $6.00, suggesting a potential upside of 312.37%. Given Ocugen's stronger consensus rating and higher probable upside, analysts clearly believe Ocugen is more favorable than Assertio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Assertio 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33Ocugen 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals believe in ASRT or OCGN? 49.0% of Assertio shares are held by institutional investors. Comparatively, 10.3% of Ocugen shares are held by institutional investors. 4.0% of Assertio shares are held by company insiders. Comparatively, 4.4% of Ocugen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has better earnings & valuation, ASRT or OCGN? Assertio has higher revenue and earnings than Ocugen. Ocugen is trading at a lower price-to-earnings ratio than Assertio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAssertio$117.10M0.76-$21.58M-$0.45-2.07Ocugen$4.75M89.46-$54.05M-$0.20-7.28 Does the media refer more to ASRT or OCGN? In the previous week, Ocugen had 5 more articles in the media than Assertio. MarketBeat recorded 11 mentions for Ocugen and 6 mentions for Assertio. Ocugen's average media sentiment score of 0.47 beat Assertio's score of 0.13 indicating that Ocugen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Assertio 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Ocugen 1 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, ASRT or OCGN? Assertio has a beta of 0.35, suggesting that its share price is 65% less volatile than the S&P 500. Comparatively, Ocugen has a beta of 4.15, suggesting that its share price is 315% more volatile than the S&P 500. SummaryOcugen beats Assertio on 9 of the 16 factors compared between the two stocks. Get Assertio News Delivered to You Automatically Sign up to receive the latest news and ratings for ASRT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ASRT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASRT vs. The Competition Export to ExcelMetricAssertioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$89.70M$2.52B$5.66B$10.31BDividend YieldN/A56.32%5.68%4.61%P/E Ratio-2.0723.2976.0726.32Price / Sales0.76572.44515.05169.28Price / Cash18.74174.1537.5661.52Price / Book0.735.1913.046.34Net Income-$21.58M$32.95M$3.29B$270.94M7 Day Performance-4.59%0.82%0.06%0.28%1 Month Performance18.37%5.81%4.21%6.87%1 Year Performance-21.19%1.76%69.54%29.24% Assertio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASRTAssertio1.8888 of 5 stars$0.94-2.0%$2.38+154.0%-18.5%$89.98M$117.10M-2.0820OCGNOcugen1.5181 of 5 stars$1.20+12.1%$6.00+400.0%+68.0%$312.77M$4.05M-6.0080High Trading VolumeAMRNAmarin0.5798 of 5 stars$14.93-0.5%$12.00-19.6%+32.4%$310.45M$228.61M-4.07360Positive NewsMNPRMonopar Therapeutics2.4698 of 5 stars$54.49+10.7%$71.75+31.7%+1,556.2%$303.68MN/A-16.3610News CoverageAnalyst ForecastGap UpSCPHscPharmaceuticals4.0806 of 5 stars$5.61-0.4%$7.78+38.7%+18.0%$300.07M$36.33M-3.1030Positive NewsGLUEMonte Rosa Therapeutics2.4967 of 5 stars$6.93+44.1%$15.33+121.3%+16.3%$297.06M$75.62M19.2590Gap DownHigh Trading VolumeMREOMereo BioPharma Group2.2125 of 5 stars$1.76-4.9%$7.40+320.5%-55.6%$294.15M$10M-25.1440Positive NewsFHTXFoghorn Therapeutics2.9318 of 5 stars$4.99-3.9%$10.67+113.8%-48.6%$293.39M$22.60M-4.19120Positive NewsENGNenGene2.5739 of 5 stars$5.97+4.6%$21.00+251.8%+12.6%$291.81MN/A-3.1431CAPRCapricor Therapeutics2.3343 of 5 stars$6.04-5.0%$22.56+273.4%-32.0%$290.76M$22.27M-3.68101Analyst ForecastGap UpKRROKorro Bio1.682 of 5 stars$31.35+1.9%$86.83+177.0%+10.0%$288.86M$6.28M-3.2270 Related Companies and Tools Related Companies Ocugen Competitors Amarin Competitors Monopar Therapeutics Competitors scPharmaceuticals Competitors Monte Rosa Therapeutics Competitors Mereo BioPharma Group Competitors Foghorn Therapeutics Competitors enGene Competitors Capricor Therapeutics Competitors Korro Bio Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASRT) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Assertio Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Assertio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ASRT Stock Alerts